Literature DB >> 9002982

Electrophoretic mobility and glycosylation characteristics of heterogeneously expressed calcitonin receptors.

M Quiza1, M Dowton, K J Perry, P M Sexton.   

Abstract

The translated calcitonin receptor (CTR) complementary DNA sequences contain potential N-linked glycosylation sites within the extracellular N-terminus. We investigated the relative molecular mass (M(r)) and degree of N-linked glycosylation of five cloned CTRs (pig, rat C1a, rat C1b, human I1-ve, and human I1+ve), together with the pig hypothalamic CTR, to analyze the potential contribution of carbohydrate moieties to the molecular identity of these receptors. Receptors were cross-linked to 125I-salmon CT with the homobifunctional reagent bis(sulfosuccinimidyl) suberate. Autoradiographic analysis of the cross-linked receptors, following SDS-PAGE, revealed apparent M(r)S, ranging between 70,000 and 80,000 for the rat, human, and pig hypothalamic receptors. However, the cloned, expressed pig CTR was much smaller (approximately 58,000). The lower M(r) of the cloned pig CTR appeared to be due to absence of N-terminal residues, but this did not impact on ligand-receptor specificity when compared with the hypothalamic pig CTR. Cleavage under nondenaturing conditions of N-linked sugars from the CTRs using endoglycosidase F (Endo F), increased the electrophoretic mobility of all receptors, except the pig CTRs, by approximately 10 kDa. Under denaturing conditions, electrophoretic mobilities increased by approximately 30 kDa for the rat C1a, rat C1b, and humanI1-ve (expressed in human embryonic kidney-293 cells) CTRs and by approximately 20 kDa for the cloned pig, pig hypothalamic, and human CTR isoforms (expressed in baby hamster kidney cells). Competition binding studies using glycosylated and partially deglycosylated (nondenaturing conditions) receptor preparations demonstrated no significant differences in binding affinity or specificity. Thus the CTRs are N-linked glycoproteins whose degree of glycosylation is both cell-type and species dependent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9002982     DOI: 10.1210/endo.138.2.4911

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.

Authors:  Sang-Min Lee; Jason M Booe; Joseph J Gingell; Virginie Sjoelund; Debbie L Hay; Augen A Pioszak
Journal:  Biochemistry       Date:  2017-06-26       Impact factor: 3.162

2.  Calcitonin Receptor N-Glycosylation Enhances Peptide Hormone Affinity by Controlling Receptor Dynamics.

Authors:  Sang-Min Lee; Yejin Jeong; John Simms; Margaret L Warner; David R Poyner; Ka Young Chung; Augen A Pioszak
Journal:  J Mol Biol       Date:  2020-02-06       Impact factor: 5.469

3.  Calcitonin receptor antibody validation and expression in the rodent brain.

Authors:  Erica R Hendrikse; Tayla A Rees; Zoe Tasma; Christelle Le Foll; Thomas A Lutz; Andrew Siow; Peter J Wookey; Christopher S Walker; Debbie L Hay
Journal:  Cephalalgia       Date:  2022-04-11       Impact factor: 6.075

4.  CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons.

Authors:  Tayla A Rees; Andrew F Russo; Simon J O'Carroll; Debbie L Hay; Christopher S Walker
Journal:  Front Physiol       Date:  2022-05-10       Impact factor: 4.755

5.  Human testis-expressed sequence 101 is limitedly distributed in germinal epithelium of testis and disappears in seminoma.

Authors:  Cong-Cong Shen; Yu-Huan Kang; Lin Yu; Dan-Dan Cui; Yi He; Jin-Liang Yang; Lan-Tu Gou
Journal:  Biol Res       Date:  2014-10-01       Impact factor: 5.612

6.  LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons.

Authors:  Anwesha Sanyal; Hailey S Novis; Emile Gasser; Steven Lin; Matthew J LaVoie
Journal:  Front Neurosci       Date:  2020-05-15       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.